Acciones de aptose biosciences inc
Compiled here, all relevant comments and discussions regarding the APS stock. Please note that all comments included here have met Investing.com's Comment Guidelines. Social media updates, opinions, and reactions on Aptose Biosciences, Inc. (APTO) aggregated in real time from around the web on NASDAQ.com 10/29/2019 · Previsiones del consenso de analistas sobre Aptose Biosciences (APS). Encuentre las estimaciones de los principales analistas del sector sobre precios para Stock analysis for Aptose Biosciences Inc (APTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 12/1/2019 · Descubre las estadísticas clave de Aptose Biosciences, Inc. (APTO), como valoraciones, estadísticas financieras del año fiscal, registros de transacciones, estadísticas de acciones y mucho más. Inicio Consulte el balance de Aptose Biosciences, que resume la posición fiscal de la compañía, incluyendo activos, pasivos y el valor accionarial de los últimos periodos. Company profile page for Aptose Biosciences Inc including stock price, company news, press releases, executives, board members, and contact information
APTO - Aptose Biosciences, Inc.
Aptose Biosciences Inc. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. Aptose Biosciences Inc., a Canada based Company, belongs to Healthcare sector and Biotechnology industry. The Aptose Biosciences Inc. has the market capitalization of $359.77M. Its EPS was $-0.56 while outstanding shares of the company were 67.50M. Aptose Biosciences, Inc. Aptose is a science-driven biotechnology company advancing highly differentiated agents to treat unmet medical needs in life-threatening cancers, such as acute myeloid leukemia ("AML"), certain B-cell malignancies, high-risk myelodysplastic syndromes ("MDS") and other hematologic malignancies. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase Ib clinical trial for the treatment of patients with relapsed/refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. View the latest APTO stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Aptose Biosciences Inc..
10/29/2019 · Previsiones del consenso de analistas sobre Aptose Biosciences (APS). Encuentre las estimaciones de los principales analistas del sector sobre precios para
Aptose Biosciences, Inc. Aptose is a science-driven biotechnology company advancing highly differentiated agents to treat unmet medical needs in life-threatening cancers, such as acute myeloid leukemia ("AML"), certain B-cell malignancies, high-risk myelodysplastic syndromes ("MDS") and other hematologic malignancies. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase Ib clinical trial for the treatment of patients with relapsed/refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. View the latest APTO stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Aptose Biosciences Inc..
12/1/2019 · Descubre las estadísticas clave de Aptose Biosciences, Inc. (APTO), como valoraciones, estadísticas financieras del año fiscal, registros de transacciones, estadísticas de acciones y mucho más. Inicio
Real-time exchange rate quote of Aptose Biosciences, Inc. including detailed information, live chart and news, profile and other market data. 11/11/2019 · Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Aptose Biosciences, Inc (APTO). 12/6/2019 · Since October, shares of APTOSE BIOSCIENCES INC - NASDAQ:APTO appear to be forming a rounding bottom and recently, have witnessed the recapture of its 200 DMA as well as a noticeable pick-up in volume as we can observe from the Daily chart above.
Stock analysis for Aptose Biosciences Inc (APTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Reciba gratis sus datos actualizados y en vivo para Aptose Biosciences Inc - Cotización, gráficos, precios, análisis, noticias y pronósticos para APTO. ¡Entrar Ver el gráfico APTOSE BIOSCIENCES INC en directo para realizar un seguimiento de los movimientos del precio de sus acciones. Encuentre predicciones del mercado, así como noticias y datos financieros de APTO. ¿Qué herramientas de análisis técnico se pueden usar para analizar APTOSE BIOSCIENCES INC? Vea diversos osciladores, medias móviles y otros indicadores técnicos Aptose Biosciences Inc. Home; About. Overview; Management Team; Board of Directors; Scientific Advisory Board Si la hora sincronizada no coincide con la hora de su ordenador, configure los parámetros hora de verano y zona horaria. Todas las horas en el sitio se convertirán
¿Qué herramientas de análisis técnico se pueden usar para analizar APTOSE BIOSCIENCES INC? Vea diversos osciladores, medias móviles y otros indicadores técnicos Aptose Biosciences Inc. Home; About. Overview; Management Team; Board of Directors; Scientific Advisory Board Si la hora sincronizada no coincide con la hora de su ordenador, configure los parámetros hora de verano y zona horaria. Todas las horas en el sitio se convertirán Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers. Detailed institutional ownership and holders of Aptose Biosciences, Inc. (APTO), including new, increased, descreased, and sold out positions.